Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,485.7
-12.0 (-0.48%)

 

  • STI Straits Times Index
    2,485.7
    -12.0 (-0.48%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,499.4
    -7.2 (-0.48%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,950.7
    -504.7 (-2.06%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,316.9
    -21.2 (-0.63%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,360.3
    40.9 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,999.4
    -59.9 (-1.18%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,078.6M
  • Value: 960.2M
  • Rise: 80
  • Fall: 274
  • Unch: 429

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.151-0.006
QT Vascular0.007-0.001
Medtecs Intl1.010-0.060
China Real Estate0.001-
ThaiBev0.595-0.010
Oceanus^0.007-
Jiutian Chemical0.043-0.002
Reenova Investment^0.003-
HPH Trust USD0.123-0.009
Sembcorp Ind1.340+0.010

World Indices

World Indices
Name Last Change
Nasdaq 10,793.3 -117.0
HSI 23,950.7 -504.7
HSCEI 9,640.4 -162.7
Jakarta 4,999.4 -59.9
Nikkei 225 23,360.3 +40.9
SSE Comp 3,316.9 -21.2
Shanghai A 3,476.3 -22.2
Shanghai B 251.3 -0.5
KOSPI 2,389.4 -23.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VERICEL CORP VERICEL CORPORATION
Updated on 18 Sep 2020 (End of trading day)
Last (USD): 19.120 Change: +0.140 High: 19.580 Remarks: -
Change (%): +0.74 Low: 18.600
Open 19.190 Yesterday's Close 18.98
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,822,789 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.21359 Trailing EPS (USD) e -0.00007 NAV (USD) b 2.3778
PE a - Trailing PE f - Price / NAV b 8.0410
Dividend (USD) d - Cash In Hand (USD) g 1.2310 Issued & Paid-up Shares c 45,250,400
Dividend Yield (%) d - Price / Cash In Hand g 15.532 Treasury Shares h -
Market Cap (M) 865.188 Enterprise Value (M) 810.983
Piotroski F Score 1 Exchange Code VCEL Par Value ( $ ) n.a.
52 Weeks Volatility (%) 74.99 Free Float (%) 98.8
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Mar 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VERICEL CORP NASDAQ 865.188 - - 8.0410 -
Industry Medical Specialties NASDAQ 2,546.862 661.257 161.391 8.1404 0.035
Local Peer INTUITIVE SURGICAL INC NASDAQ 76,718.735 55.621 67.534 8.7774 -
Local Peer DEXCOM INC NASDAQ 37,273.396 368.679 182.088 27.5304 -
Local Peer IDEXX LABORATORIES INC NASDAQ 30,174.005 70.546 65.581 110.5412 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 25,300.317 77.918 30.242 9.3947 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 25,288.167 57.113 14.864 8.8885 -
Local Peer HOLOGIC INC NASDAQ 16,463.676 - 24.937 7.3006 -
Local Peer INSULET CORPORATION NASDAQ 14,772.676 1,273.530 813.832 26.2252 -
Local Peer MASIMO CORPORATION NASDAQ 12,269.361 62.530 55.209 9.1253 -
Local Peer ABIOMED INC NASDAQ 11,940.688 58.819 75.253 10.8370 -
Local Peer NOVOCURE LTD NASDAQ 11,194.817 - 948.955 41.7997 -
Local Peer DENTSPLY SIRONA INC NASDAQ 10,122.920 38.505 - 2.1802 0.820
Local Peer QUIDEL CORP NASDAQ 7,941.573 108.907 51.337 12.9826 -
Other Local Peers IRHYTHM TECHNOLOGIES INC (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), BRUKER CORPORATION (NASDAQ), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), NUVASIVE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), ATRICURE INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), CAREDX INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INMODE LTD (NASDAQ), MESA LABORATORIES INC (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), SI BONE INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INOGEN INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), ZYNEX INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), QUOTIENT LTD (NASDAQ), SURMODICS INC (NASDAQ), AXOGEN INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANTARES PHARMA INC (NASDAQ), VIEWRAY INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CUTERA INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), PROFOUND MED CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), IRADIMED CORP (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), MISONIX INC (NASDAQ), TELA BIO INC (NASDAQ), DERMTECH INC (NASDAQ), SIENTRA INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), FONAR CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), SOLITON INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), INTRICOM CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BIOMERICA INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), NEURONETICS INC (NASDAQ), ELECTROCORE INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CONFORMIS INC (NASDAQ), NEPHROS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), TITAN MEDICAL INC (NASDAQ), NEOVASC INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), IMMUCELL CORP (NASDAQ), APPLIED UV INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), AVINGER INC (NASDAQ), NEUROTROPE INC (NASDAQ), BIOLASE INC (NASDAQ), IRIDEX CORP (NASDAQ), CHF SOLUTIONS INC (NASDAQ), CELSION CORPORATION (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), CHECK-CAP LTD (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), CYANOTECH CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), DIGIRAD CORP (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CANCER GENETICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), NANOVIBRONIX INC (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 189,198.836 51.609 61.568 6.1874 1.230
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 169,727.460 45.922 45.798 5.6813 0.179
Global Peer DANAHER CORP NYSE 146,358.171 58.807 50.104 4.4359 0.323
Global Peer MEDTRONIC PLC NYSE 144,638.072 30.202 32.783 2.8757 2.003
Global Peer STRYKER CORP NYSE 77,517.566 37.214 48.418 6.0779 1.031
Global Peer BECTON DICKINSON & CO NYSE 67,220.621 62.126 86.848 2.7985 1.239
Global Peer BOSTON SCIENTIFIC CORP NYSE 55,052.182 11.713 13.832 3.5254 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 51,728.851 49.411 69.565 13.4741 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,345.743 32.420 38.006 3.4425 1.968
Global Peer BAXTER INTERNATIONAL INC NYSE 42,002.069 41.960 45.457 5.1676 1.024
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TOPGLOV (Bursa), Top Glove (SGX), VARIAN MEDICAL SYSTEMS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), WATERS CORP (NYSE), HARTA (Bursa), QIAGEN NV (NYSE), WEIGAO GROUP (HKEx), COCHLEAR LTD (ASX), MICROPORT (HKEx), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), SUPERMX (Bursa), VENUS MEDTECH-B (HKEx), HAEMONETICS CORP (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), KANGJI MEDICAL (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), AK MEDICAL (HKEx), EBOS GROUP (ASX), PEIJIA-B (HKEx), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), CANTEL MEDICAL CORP (NYSE), AVANOS MEDICAL INC (NYSE), CIRC (HKEx), NANOSONICS LIMITED (ASX), LIFETECH SCI (HKEx), KDL MEDICAL (HKEx), VAPOTHERM INC (NYSE), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), Medtecs Intl (SGX), MCP INCOME OPPORTUNITIES TRUST (ASX), YESTAR HEALTH (HKEx), UG Healthcare (SGX), GOLDEN MEDITECH (HKEx), PW MEDTECH (HKEx), AROA BIOSURGERY LTD (ASX), STEREOTAXIS INC (NYSE American), CORMEDIX INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), INVACARE CORP (NYSE), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), ALPHA PRO TECH (NYSE American), ATOMO DIAGNOSTICS LIMITED (ASX), MODERN DENTAL (HKEx), EMVISION MEDICAL DEVICES LTD (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), VINCENT MED (HKEx), LKL (Bursa), RESPIRI LTD (ASX), ELECTROMED INC (NYSE American), VOLITIONRX LIMITED (NYSE American), YUNNAN ENERGY (HKEx), SDI LTD (ASX), DAXOR CORP (NYSE American), RESAPP HEALTH LIMITED (ASX), Biolidics (SGX), IMAGION BIOSYSTEMS LIMITED (ASX), MICRO-X LTD (ASX), IMPEDIMED LIMITED (ASX), COMPUMEDICS (ASX), MILESTONE SCIENTIFIC INC (NYSE American), RESONANCE HEALTH LTD (ASX), ONCOCYTE CORP (NYSE American), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), KELFRED (HKEx), OPTISCAN IMAGING (ASX), NOVA EYE MEDICAL LIMITED (ASX), DIMERIX LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), LIFE HEALTHCARE (HKEx), Yunnan Energy (SGX), CARDIEX LTD (ASX), OVENTUS MEDICAL LTD (ASX), LBT INNOVATIONS LTD (ASX), METALICITY LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), USCOM LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE), XTANT MEDICAL HLDGS INC (NYSE American), ADHERIUM LIMITED (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), Annica (SGX), STHAI (SET), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), NEUROTECH INTERNATIONAL LTD (ASX), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.525
+8.67 %
10 Days -+3.230
+20.33 %
20 Days -+2.870
+17.66 %
Medium Term Return 3 Months -+4.280
+28.84 %
6 Months -+11.720
+158.38 %
1 Year -+3.160
+19.80 %
Long Term Return 2 Years -+4.320
+29.19 %
3 Years -+14.270
+294.23 %
5 Years -+16.720
+696.67 %
Annualised Return Annualised --
+51.45 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.780 - 19.640 Change From 1 Year Low +12.340 % Change From 1 Year Low (%) +182.01
Change From 1 Year High -0.520 % Change From 1 Year High (%) -2.65
2 Years Range 6.780 - 21.005 Change From 2 Years Low +12.340 % Change From 2 Years Low (%) +182.01
Change From 2 Years High -1.885 % Change From 2 Years High (%) -8.97
5 Years Range 1.690 - 21.005 Change From 5 Years Low +17.430 % Change From 5 Years Low (%) +1031.36
Change From 5 Years High -1.885 % Change From 5 Years High (%) -8.97
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Sep 2020 19.190 19.580 18.600 19.120 1,822,789 -
17 Sep 2020 19.140 19.640 18.690 18.980 719,308 -
16 Sep 2020 18.500 19.420 17.730 18.950 737,663 -
15 Sep 2020 17.750 18.470 17.475 18.120 449,380 -
14 Sep 2020 17.360 17.680 17.060 17.595 538,992 -
11 Sep 2020 16.990 17.500 16.880 17.160 412,749 -
10 Sep 2020 16.290 17.530 16.190 16.900 497,276 -
09 Sep 2020 15.920 16.535 15.550 16.320 491,131 -
08 Sep 2020 15.620 16.350 15.370 15.880 490,483 -
04 Sep 2020 15.270 16.010 14.840 15.890 769,595 -
03 Sep 2020 15.930 16.210 15.180 15.220 424,120 -
02 Sep 2020 16.070 16.175 15.780 15.870 679,606 -
01 Sep 2020 15.810 16.090 15.550 15.910 1,176,373 -
31 Aug 2020 16.470 16.490 15.680 15.850 550,864 -
28 Aug 2020 16.370 16.380 15.710 16.370 492,438 -
27 Aug 2020 16.780 16.930 16.490 16.610 213,922 -
26 Aug 2020 16.830 17.100 16.690 16.780 257,803 -
25 Aug 2020 16.550 16.910 16.395 16.800 315,625 -
24 Aug 2020 16.540 16.550 15.470 16.250 621,167 -
21 Aug 2020 16.810 16.880 16.269 16.460 296,986 -
20 Aug 2020 16.360 16.880 16.120 16.780 311,269 -
19 Aug 2020 16.250 16.870 16.075 16.520 426,397 -
Summary
Current 2 Weeks
(04 Sep 2020 to 18 Sep 2020)
15.270 19.640 14.840 19.120 6,929,366 -
Previous 2 Weeks
(21 Aug 2020 to 03 Sep 2020)
16.810 19.640 14.840 15.220 5,028,904 -
4 Weeks from
(24 Jul 2020 to 20 Aug 2020)
15.270 19.640 14.840 16.780 9,223,484 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.